Abstract
Arsenic is a carcinogen associated with skin lesions and cardiovascular diseases. The Colla population from the Puna region in Northwest Argentinean is exposed to levels of arsenic in drinking water exceeding the recommended maximum by a factor of 20. Yet, they thrive in this challenging environment since thousands of years and therefore we hypothesize strong selection signatures in genes involved in arsenic metabolism. We analyzed genome-wide genotype data for 730,000 loci in 25 Collas, considering 24 individuals of the neighbouring Calchaquíes and 24 Wichí from the Gran Chaco region in the Argentine province of Salta as control groups. We identified a strong signal of positive selection in the main arsenic methyltransferase AS3MT gene, which has been previously associated with lower concentrations of the most toxic product of arsenic metabolism monomethylarsonic acid. This study confirms recent studies reporting selection signals in the AS3MT gene albeit using different samples, tests and control populations.
Keywords: Arsenic drinking water, Collas, Puna, Methyltransferase, Calchaquíes
1. Introduction
High levels of arsenic in drinking water are found in countries all over the world [1]. Arsenic mainly originates from minerals in the ground and enters the food chain through drinking water and food sources such as crop plants [2]. Anthropogenic actions like mining and pesticide use contribute to elevated levels of arsenic [3].
Long-term exposure to arsenic can result in cancer, skin lesions, as well as cardiovascular and pulmonary diseases [4]. However, not only at a later stage in life but already at an early age arsenic exposure can have drastic consequences. Arsenic can cross the placental barrier and thus affect the foetal development. Arsenic alters immune response modulator concentrations measured in breast milk [5] as well as in newborn cord blood [6]. Subsequently, high arsenic intake by drinking water in early childhood increases the risk of respiratory infections and diarrhea in infants [7] as well as liver cancer associated mortality [8]. This suggests that populations exposed to high levels of arsenic over long periods of time may possess some kind of protection against arsenic toxicity.
In the body, inorganic arsenic is modified to monomethylarsonic acid (MMA) and subsequently to dimethylarsinic acid (DMA) [9] by methyltransferases. The second reaction occurs much faster due to an increased substrate affinity of the enzyme for MMA and therefore DMA is the predominant end product of arsenic metabolism [10]. Inorganic arsenic, MMA and DMA are excreted in the urine and can be used to measure arsenic metabolism. The most toxic arsenic product is MMA; thus, the first step in the arsenic metabolism is considered to be rather an activation than a detoxification of arsenic [11]. Hence, low levels of MMA in comparison to DMA in urine are beneficial to reduce its toxicity [12].
In the highlands of Northwest Argentina, the Puna, high levels of arsenic in water have been present since many thousands of years [13]. In some locations levels exceed the maximum safe level set by the WHO of 10 µg/l by a factor 20 [9]. San Antonio de los Cobres, in the heart of the Puna region, is one of such localities [9,14]. Yet, its inhabitants show unusually low levels of excreted MMA metabolite relative to DMA and inorganic arsenic [9]. In agreement with this observation, Puna highlanders show increased frequencies of arsenic methyltransferase (AS3MT) alleles that have been associated with low MMA urine concentrations [15–17]. Allele differences in Collas were associated with enzyme expression levels [16] and resulting concentrations of arsenic metabolites. Lower levels of MMA were found in Collas compared to Bangladeshi [15], Chinese or Tibetans [18] exposed to permanently elevated arsenic levels in drinking water. Genes responsible for the metabolism of arsenic, therefore, may have been targets of strong positive selection among these populations. Levels of MMA and DMA have been recently associated with various SNPs near AS3MT in women from the Colla population of San Antonio de los Cobres in the Argentinean Puna region [19]. Moreover, an allele frequency based selection test applied on genome-wide genotype data in the same study suggested AS3MT as one of the main candidates of selection in this population.
In this study, we investigate the strength of the selection pressure exerted by elevated arsenic levels on the genome of a different subset of men and women from the Colla population from San Antonio de los Cobres and surrounding villages. We use two neighboring groups, the Calchaquí and the Wichí as control populations. We also assessed genome-wide genotype data using distinct allele frequency based selection test and were able to confirm strong signatures within and near the AS3MT gene, thus underlining the key role of this gene in the adaptation to environmental arsenic.
2. Materials and methods
2.1. Subjects and ethical approval
Individuals with indigenous ancestry from three regions of the Northwestern Argentinean province of Salta were recruited to participate in this study in April 2011: (1) Collas from the Andean Plateau or Puna (>3500 m), (2) Calchaquíes from Cachi in the Calchaquí valleys at 2300 m and (3) Wichí from the plains of the Gran Chaco region near Embarcación (Fig. 1). We used our previously published data [20,21] for 730,525 single nucleotide polymorphisms (SNPs) genotyped in 25 Collas (11 men, 14 women), 24 Calchaquíes (10 men, 14 women) and 24 Wichí (12 men, 12 women). In the Colla sample, 16 individuals were from San Antonio de los Cobres, where arsenic levels reach 214 µg/l [14]; 7 were from Tolar Grande with arsenic levels of 4 µg/l and one individual was from Olacapato, where arsenic levels are 12 µg/l. Arsenic concentrations for the exact sampling locations in the Gran Chaco regions were not available, however in surrounding locations arsenic concentrations were measured to be: Las Varas 0 µg/l, Pinchanal 19.5 µ/l, General Ballivián 4 µg/l, Tartagal 2.3 µg/l [22]. Concentrations in Cachi (Río Las Trancas) were 3.1 µg/l [22].
Fig. 1. Sampling locations and arsenic levels in the province of Salta, Argentina.
Stars denote sampling locations, circles levels of arsenic. Sampling locations of the Wichí population in the Gran Chaco region are (left to right): Embarcación, Carboncito, Misión Chacheña, Dragones (purple stars). Arsenic concentrations in surrounding locations were measured to be: Las Varas 0 µg/l, Pinchanal 19.5 µg/l, General Ballivián 4 µg/l, Tartagal 2.3 µg/l [22]. Calchaquíes originated from Cachi (turquoise star) with an arsenic level of 3.1 µg/l [22]. Collas (pink stars) were sampled in: San Antonio de los Cobres (arsenic level: 214 µg/l), Tolar Grande (arsenic level: 4 µg/l) and Olacapato (arsenic level of 12 µg/l) [14].
Only healthy unrelated adults who gave written informed consent were included in the study. The study was approved by the University of East Anglia Research Ethics Committee, the Ministry of Health of the Province of Salta (Ministerio de Salud Pública, Salta, Argentina) and the University of Cambridge’s Human Biology Research Ethics Committee (HBREC.2011.01).
2.2. Genotype data analysis
In total, 726,090 SNPs passed a genotype call rate of >98% and were included in downstream analyses [20,21]. Two tests for positive selection were employed to analyze genome-wide signatures of arsenic adaptation. The pairwise fixation index (FST) was used as a measure of population differentiation [23] between Collas and Wichí, and between Calchaquí and Wichí using the programme GENEPOP [24]. We defined genomic windows of 200 kb and used maximal FST values to rank them. Only the top 1% was considered for analyses. Because the direction of the pairwise FST signatures cannot be determined (i.e. the signal can be due to extreme allele frequencies in either of the two populations), we also used the population branch statistic (PBS) to pinpoint allele differentiation to the population of interest [25,26]. PBS is based on pairwise FST of three populations. Collas and Calchaquíes were each compared to Wichí and Eskimos [27]. Eskimos were chosen as the closest non-American outgroup genotyped on the same genotyping platform as Collas, Calchaquíes and Wichí. They originated from Novoe Chaplino, Chukotka Autonomous Okrug in Northeast Siberia [27]. PBS was calculated following Yi et al. [25] using a modified approach from Pickrell et al. [28] for 100 kb windows ranked by maximum PBS values [21]. Regional analysis of linkage disequilibrium was carried out with HaploView 4.2 [29].
As the first step in functional interpretation of the results of selection scanning, we compiled a list of genes known to be involved in arsenic metabolism. We included genes from three different sources: (a) from the Gene Ontology (GO) database AmiGO we extracted genes that matched the search keyword ‘arsen’ to include metabolites of arsenic such as arsenate and arsenite [30]; (b) from the gene information database GeneCards [31] we extracted genes associated with any compound containing the keyword ‘arsen’; (c) additional methyltransferases were extracted from literature [15,32]. The final candidate gene list consisted of 35 unique genes (Table A1). The selection test results were subsequently screened for these 35 candidate genes of arsenic metabolism.
Allele frequency differences between the three populations were assessed with One Way Analysis of Variance (ANOVA) implemented in the Statistical Package for Social Sciences (SPSS), version 20.
3. Results
We conducted whole genome scans in Collas and Calchaquíes to identify genetic loci that showed higher than genome-wide average allelic differences between populations (FST and PBS tests). These scans highlighted the arsenic methyltransferase (AS3MT) gene as being highly differentiated in the Colla population. The gene was among the top 15 windows in PBS of Colla highlanders (Fig. 2) and among the top 40 windows of pairwise FST between Collas and Wichí.
Fig. 2. Window PBS scores across the genome in Collas.
The blue line indicates the top 1% of hits. The fourth highest cluster overall is found on chromosome 10. The green circles indicate the PBS hits ±1 Mb of AS3MT. The highest scoring SNP overall lies on chromosome 11 and falls within a gene free region. The hit on chromosome 21 is located within CBS, which regulates cerebral blood flow velocity.
The pairwise FST signal was exclusively driven by two SNPs, one within the AS3MT gene (rs1046778, FST = 0.606) and another one 1 kb upstream of AS3MT (rs7085104, FST = 0.564; genome-wide mean FST = 0.041). Specific variants of these alleles have been associated with beneficial arsenic metabolism [15]. The C allele of the T/C SNP rs1046778 was more frequent in Collas than in Wichí (74% and 8% respectively). The G allele of the G/A SNP rs7085104 was also prevalent in Collas (78% compared to 15% in Wichí). This is consistent with previously reported frequencies for these alleles [15], which have been associated with overall decreased expression of AS3MT and lower excreted MMA levels [15]. Engström et al. showed a 175% increase of AS3MT expression in homozygous carriers of the T allele at the rs1046778 locus compared to homozygotes of the C allele. Overall, 92% of Collas were at least heterozygous for the C and G allele on the same chromosomal strand corresponding to both functionally advantageous alleles (Fig. 3). The percentage of homozygotes for both beneficial alleles is decreased in individuals from the Calchaquí valley, but not significantly. However, allele frequencies in both Collas and Calchaquíes differed significantly from Wichí (p < 0.001, ANOVA). A recent study using a dataset with greater SNP density, however, could not identify these two previously highlighted SNPs among the top 20 SNPs associated with MMA or DMA concentrations in 124 women from San Antonio de los Cobres [19].
Fig. 3. Distribution of beneficial CG alleles in Argentinean populations.
The majority of Collas has two copies of the beneficial CG alleles (rs1046778, rs7085104) within and near AS3MT, while Calchaquíes mainly carry one copy of the specific alleles. In Wichí most individuals have no copy of the beneficial alleles. Allele frequencies differ significantly between Collas and Wichí and Calchaquíes and Wichí (p <0.001).
In agreement with our FST results, PBS comparisons of Collas, Wichí, and Eskimos highlighted a window containing AS3MT and two neighbouring genes, CNNM2 and WBP1L (Table A2). However, this test identified a different set of SNPs than FST in the surrounding region of AS3MT. The SNP (rs12221064) nearest to the gene region identified by PBS was located 15 kb downstream of AS3MT within CNNM2 (Table A2) and ranked 11th. Other high-ranking SNPs included rs17115100, within CYP17A1, 38 kb upstream of AS3MT (ranking 4th), and rs11191514 within CNNM2, 112 kb downstream (ranking 10th) (Table A2). The recent study by Schlebusch and colleagues associated rs17115100 and rs11191514 with percentage of MMA in urine and rs17115100 also with percentage of DMA in urine [19]. The allele frequency FST based selection test used by these authors (LSBL, locus specific branch length test) also highlighted AS3MT as top candidate of selection in the Colla population with Peruvians and Colombians as control populations. We previously reported haplotype based selection tests in Collas [21] but AS3MT was not among the top 1% haplotypes. However, a regional haplotype analysis 1 Mb up and downstream of AS3MT identified a haplotype block of 499 kb containing AS3MT (Fig. A1).
We repeated the PBS test using a neighbouring population to the Collas, the Calchaquíes, comparing it to Wichí and Eskimos. This test identified the same upstream SNP (rs17115100), albeit the SNP containing window ranked much lower (50th). While the top 1% FST results from Calchaquíes lacked AS3MT, it contained another gene from the candidate gene list, the cyclin-dependent kinase inhibitor 1A (CDKN1A) gene (rank 60). This kinase inhibitor is a modulator of the cell cycle and was inferred by orthologs to respond to an arsenic-containing substance (G0:0046685, evidence: inferred through electronic annotation).
AS3MT was the only of the 35 arsenic candidate genes (Table A1) showing a signature of selection with two selection tests in the same population.
4. Discussion
High concentrations of arsenic in drinking water represent a strong environmental stressor, driving significant adaptive change in the highland populations of the Argentinean Puna. In this study, AS3MT was identified by our genome-wide scans as the main outcome of positive selection. Alleles within or nearby this gene are highly differentiated and appear within the top 1% of ca. 13,000 windows across the genome. AS3MT had not been identified previously the top 1% of two haplotype based tests (integrated haplotype score, iHS and cross population extended haplotype homozygosity, XP-EHH) in Collas [21]. However, the minimum SNP density for iHS in a 200 kb window was not reached in the respective window containing the gene; therefore, no iHS test statistic could be calculated. XP-EHH neither highlighted the respective window as a particular long high frequency haplotype [21].
Thus, the selection signature of AS3MT was not identified by our previous haplotype based tests [21] but only by allele frequency based tests. Though a similar study also failed to identify a strong selection signal with iHS, it reported the average iHS values in a 1 Mb window around AS3MT to be among the top 3%. In both studies, allele frequency based tests lead to more conclusive results, suggesting selection from standing variation in the ancestral population prior to the exposure to high arsenic concentrations. The alleles identified by our present study have been functionally evaluated and associated with reduced MMA concentrations in the Colla population of San Antonio de los Cobres [15,19]. High concentrations of MMA are associated with arsenic related diseases [12]; thus, the metabolism of Argentine Puna inhabitants seems fine-tuned to reduce toxic MMA [9]. Only AS3MT could be highlighted from the arsenic candidate gene list by two selection tests using a genome-wide genotype approach. An alternative arsenic methyltransferase N6AMT1, which was also associated with lower MMA in Collas [33], did not reach genome-wide significance (data not shown).
The findings of our study are therefore well in agreement with a previous recent report [19] suggesting selection pressure from arsenic water in the Colla population, albeit analyzing different individuals, using distinct control populations and different FST based selection tests (PBS and FST instead of LSBL). Alleles both within and around AS3MT appear to be the target of strong positive selection. The SNPs around AS3MT could be in linkage with a regulatory or functional variant or could itself influence AS3MT expression. An analysis of the region revealed a haplotype block of approximately 499 kb around the gene region (Fig. A1), thus suggesting selection of surrounding SNPs. Schlebusch et al. [19] also highlighted selection signatures outside the coding region of the AS3MT gene. Whole genome scans have the potential to reveal more distantly located loci with functional relevance, which may be overlooked by targeted resequencing of specific gene regions. Besides reporting strong signatures around AS3MT, we also highlighted adjacent genes, such as CMMN2 or CYP17A1, and cannot unequivocally exclude that these may also contribute in particular to the PBS selection signal. However, considering the high FST scores within AS3MT, the functional relevance of this gene in the arsenic metabolism and association of overrepresented alleles in Collas with its expression [15], AS3MT is a likely candidate of selection. Nevertheless functional in vitro and in vivo studies of alleles are necessary for a more conclusive interpretation. In this regard, it is worth noting that the neighboring genes CNNM2 and WPB1L (Table A2), have been shown to be differentially methylated in the Colla population [16]. Since methylation reduces gene expression, a decreased level of the arsenic methyltransferase in peripheral blood was observed [16]. The reduced expression of this enzyme is associated with lower levels of MMA [15] and thus most likely beneficial in an environment with elevated arsenic concentrations.
It is interesting to note, that the FST values for the two highlighted alleles within 1 kb upstream of the AS3MT gene were 10 fold higher (0.606 and 0.564) than the gene’s average FST of 0.053 calculated in another study, which compared Collas to indigenous Peruvians [17]. This underlines the extreme allele differentiation of two functionally associated SNPs compared to the complete gene region.
Significant differences in the allele frequency of AS3MT were also observed between Calchaquíes, Wichí and Eskimos, even though arsenic levels in ground water in the Calchaquí region are lower than those in the Puna [22]. The selection signature of AS3MT ranks lower in Calchaquíes than in Collas albeit still among the top 1%, thus, implying either a reduced selection pressure in the Calchaquí population or gene flow from Collas [20]. Calchaquíes also show a selection signature around CDKN1A, as indicated by pairwise FST, although this signature is less strong than that of AS3MT in Collas. The functional significance of this cell cycle regulator for arsenic metabolism remains to be clarified.
In summary, our study confirms previous claims that positive selection has shaped allele frequencies of AS3MT to allow adaptation to the extremely toxic element arsenic [19]. We show signatures of positive selection driving allele frequencies in Collas and, to a smaller degree, in the neighboring Calchaquí population. Selected alleles have enabled these populations to thrive for thousands of years despite their constant exposure to high levels of arsenic in drinking water.
5. Conclusion
The toxicant arsenic was shown to shape allele frequencies of the main arsenic methyltransferase in Argentinean Collas and Calchaquíes. This study confirms recent findings highlighting the strong selection pressure of the environmental carcinogen arsenic at a genome-wide level. This suggests that natural selection has given carriers of beneficial alleles higher reproductive success to thrive despite the daily consumption of high levels of arsenic.
Acknowledgements
We greatly appreciate the support of the Ministry of Health of the Province of Salta, Argentina and local hospital authorities for facilitating the data collection. We are particularly indebted to the people of Cachi, the Puna and the Gran Chaco region for their generous participation in this study.
Funding sources
This work was supported by European Research Council Starting Investigator (FP7-261213, TK), a starting investigator grant from the University of East Anglia (RC-158, MM), a Young Explorers Grant from the National Geographic Society (8900-11, CE) and a Sir Henry Wellcome Postdoctoral Fellowship (WT100066MA, TA). Publication and open access costs were covered by the University of Winchester. The funding bodies had no influence on the study design or analysis, data interpretation or article preparation.
Appendix A.
Fig. A1. Haplotype analysis of SNPs ±1 Mb around AS3MT.
The region includes SNPs located 1 Mb up and downstream of AS3MT on chromosome 10 between positions 104, 629, 210–104, 661, 656. The central largest triangle includes AS3MT and spans 499 kb. SNPs are represented on the top and the linkage disequilibrium (LD) degree is displayed below by colour. Red squares represent strong LD (D’ = 1) with a high logarithm of odds (LOD) score, i.e. the probability of linkage between 2 loci is very high; purple: high D’, low LOD score; white: low D’ and low LOD score. Black triangles indicate haplotype blocks calculated by the programme Haploview [29]. Only heterozygous SNPs are displayed.
Table A1. Arsenic detoxification associated candidate genes.
| Source | Gene | Name |
|---|---|---|
| AmiGO: “arsen” associated ontology | ABCC2 | ATP-binding cassette sub-family C member 2 |
| AS3MT | Methylarsonite methyltransferase (arsenite methyltransferase) | |
| ASNA1 | Arsa (Bacterial) arsenite transporter, Atp-binding, homolog 1 | |
| CDKN1A | Cyclin-dependent kinase inhibitor 1 | |
| CPEB2 | Cytoplasmic polyadenylation element-binding protein 2 | |
| CPOX | Coproporphyrinogen oxidase | |
| CYP1A1 | Cytochrome P1-450, dioxin-inducible | |
| DDX3X | DEAD (Asp-Glu-Ala-Asp) box helicase 3, X-linked | |
| FECH | Errochelatase | |
| GCLC | Glutamate-cysteine ligase, catalytic subunit | |
| GLRX2 | Glutaredoxin 2 | |
| GSTO1 | Glutathione S-transferase omega-1 (monomethylarsonic acid reductase) | |
| GSTO2 | Glutathione S-transferase omega-2 (monomethylarsonic acid reductase) | |
| HMOX1 | Heme Oxygenase 1 | |
| MKNK2 | MAP kinase interacting serine/threonine kinase 2 | |
| PPIF | Peptidylprolyl isomerase F (cyclophilin F) | |
| PTEN | Phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase | |
| RBM4 | RNA-binding motif protein 4 | |
| RNF4 | RING finger protein 4 | |
| SLC34A1 | Solute Carrier family 34 member 1 | |
| SRRT | Serrate RNA effector molecule homolog (arsenite-resistance protein 2) | |
| TNFRSF11B | Tumor necrosis factor receptor superfamily member 11B | |
| UROS | Uroporphyrinogen-Ill synthase | |
| ZFAND1 | Zinc finger, AN1-type domain 1 | |
| ZFAND2A | Zinc finger, AN1-type domain 2A (arsenite inducible RNA Associated protein) | |
| ZFAND2B | Zinc finger, AN1-type 2B (arsenite-inducible RNA-associated protein-like protein) | |
| Gene cards: “arsen” associated gene name | METTL18 | Methyltransferase-like protein 18 (arsenic-transactivated protein 2) |
| POLE3 | Polymerase (DNA directed), epsilon 3 (arsenic-transactivated protein) | |
| SERPINH1 | Serine (or cysteine) proteinase inhibitor, clade H (arsenic-transactivated protein 3) | |
| SPDL1 | Spindly homolog (drosophila) (arsenite-related gene 1 protein) | |
| Literature: arsenic associated methyl-transferases | BHMT | Betaine-homocysteine S-methyltransferase [15] |
| DNMT1 | DNA (cytosine-5)-methyltransferase 1 [15] | |
| DNMT3B | DNA (cytosine-5)-methyltransferase 3B [15] | |
| N6AMT1 | N-6 Adenine-specific DNA methyltransferase 1 [32] | |
| PEMT | Phosphatidylethanolamine N-methyltransferase [15] |
Table A2. Top 15 windows of PBS in Collas.
| Rank | Genes in window | Window location | PBS | Max. score position |
|---|---|---|---|---|
| 1 | ACY3, ALDH3B2, TBX10 | 11: 67400,000-67500000 | 1.188 | 23 kb Downstream ALDH3B2 |
| 2 | CBS, MX2, PKNOX1 | 21: 44400000-44500000 | 1.005 | Within CBS and MX2 |
| 3 | HRH1, RP11-572M11.3, SNORD112 | 3: 112800000-112900000 | 0.993 | Within HRH1 |
| 4 | CYP17A1, CYP17A1-AS1, WBP1L | 10: 104500000-104600000 | 0.965 | Within CYP17A1,38 kb upstream of AS3MT |
| 5 | TSPAN18 | 11: 44700000-44800000 | 0.955 | 27 kb Upstream of TSPAN18 |
| 6 | RN7SL710P | 14:97900000-98000000 | 0.950 | 36 kb Upstream of RN7SL710P |
| 7 | No gene | 13: 103800000-103900000 | 0.934 | n.a. |
| 8 | ATP2B2, ATP2B2-1T1, ATP2B2-1T2 | 3: 10600000-10700000 | 0.929 | Within ATP2B2 |
| 9 | PLCH1, PLCH1-AS1 | 3: 155100000-155200000 | 0.925 | Within PLCH1 |
| 10 | CNNM2 | 10: 104700000-104800000 | 0.906 | Within CNNM2 |
| 11 | CNNM2, C10orf32, AS3MT | 10: 104600000-104700000 | 0.906 | Within CNNM2,15 kb downstream of AS3MT |
| 12 | LHFP | 13: 40100000-40200000 | 0.893 | Within LHFP |
| 13 | CRYAA, U2AF1 | 21: 44500000-44600000 | 0.872 | Within MX2 |
| 14 | L1NC00856 | 10: 80300000-80400000 | 0.871 | Within LINC00856 |
| 15 | PDSS1 | 10: 26900000-27000000 | 0.870 | 617 bp Upstream of PDSS1 |
Footnotes
Conflict of interest
The authors declare that there are no conflicts of interests.
References
- [1].van Halem B, Amy SAGL, van Dijk JC. Arsenic in drinking water: a worldwide water quality concern for water supply companies. Drinking Water Eng Sci. 2009;2:29–34. [Google Scholar]
- [2].Azizur Rahman M, Hasegawa H, Mahfuzur Rahman M, Mazid Miah MA, Tasmin A. Arsenic accumulation in rice (Oryza sativa L.): human exposure through food chain. Ecotoxicol Environ Saf. 2008;69:317–324. doi: 10.1016/j.ecoenv.2007.01.005. [DOI] [PubMed] [Google Scholar]
- [3].Nordstrom DK. Public health. Worldwide occurrences of arsenic in ground water. Science. 2002;296:2143–2145. doi: 10.1126/science.1072375. [DOI] [PubMed] [Google Scholar]
- [4].WHO. Researchers warn of impending disaster from mass arsenic poisoning. 2000 Press Release. [Google Scholar]
- [5].Raqib R, Ahmed S, Sultana R, Wagatsuma Y, Mondal D, Hoque AM, Nermell B, Yunus M, Roy S, Persson LA, Arifeen SE, et al. Effects of in utero arsenic exposure on child immunity and morbidity in rural Bangladesh. Toxicol Lett. 2009;185:197–202. doi: 10.1016/j.toxlet.2009.01.001. [DOI] [PubMed] [Google Scholar]
- [6].Fry RC, Navasumrit P, Valiathan C, Svensson JP, Hogan BJ, Luo M, Bhattacharya S, Kandjanapa K, Soontararuks S, Nookabkaew S, Mahidol C, et al. Activation of inflammation/NF-kappaB signaling in infants born to arsenic-exposed mothers. PLoS Genet. 2007;3:e207. doi: 10.1371/journal.pgen.0030207. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [7].Farzan SF, Korrick S, Li Z, Enelow R, Gandolfi AJ, Madan J, Nadeau K, Karagas MR. In utero arsenic exposure and infant infection in a United States cohort: a prospective study. Environ Res. 2013;126:24–30. doi: 10.1016/j.envres.2013.05.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [8].Liaw J, Marshall G, Yuan Y, Ferreccio C, Steinmaus C, Smith AH. Increased childhood liver cancer mortality and arsenic in drinking water in northern Chile. Cancer Epidemiol Biomarkers Prev. 2008;17:1982–1987. doi: 10.1158/1055-9965.EPI-07-2816. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [9].Vahter M, Concha G, Nermell B, Nilsson R, Dulout F, Natarajan AT. A unique metabolism of inorganic arsenic in native Andean women. Eur J Pharmacol. 1995;293:455–462. doi: 10.1016/0926-6917(95)90066-7. [DOI] [PubMed] [Google Scholar]
- [10].Lin S, Shi Q, Nix FB, Styblo M, Beck MA, Herbin-Davis KM, Hall LL, Simeonsson JB, Thomas DJ. A novel S-adenosyl-l-methionine:arsenic(III) methyltransferase from rat liver cytosol. J Biol Chem. 2002;277:10795–10803. doi: 10.1074/jbc.M110246200. [DOI] [PubMed] [Google Scholar]
- [11].Hall MN, Gamble MV. Nutritional manipulation of one-carbon metabolism: effects on arsenic methylation and toxicity. J Toxicol. 2012;2012:595307. doi: 10.1155/2012/595307. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [12].Smith AH, Steinmaus CM. Health effects of arsenic and chromium in drinking water: recent human findings. Annu Rev Public Health. 2009;30:107–122. doi: 10.1146/annurev.publhealth.031308.100143. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [13].Concha G, Nermell B, Vahter M. Spatial and temporal variations in arsenic exposure via drinking-water in northern Argentina. J Health Popul Nutr. 2006;24:317–326. [PMC free article] [PubMed] [Google Scholar]
- [14].Concha G, Broberg K, Grander M, Cardozo A, Palm B, Vahter M. High-level exposure to lithium, boron, cesium, and arsenic via drinking water in the Andes of northern Argentina. Environ Sci Technol. 2010;44:6875–6880. doi: 10.1021/es1010384. [DOI] [PubMed] [Google Scholar]
- [15].Engström K, Vahter M, Mlakar SJ, Concha G, Nermell B, Raqib R, Cardozo A, Broberg K. Polymorphisms in arsenic(+III oxidation state) methyltransferase (AS3MT) predict gene expression of AS3MT as well as arsenic metabolism. Environ Health Perspect. 2012;119:182–188. doi: 10.1289/ehp.1002471. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [16].Engström KS, Hossain MB, Lauss M, Ahmed S, Raqib R, Vahter M, Broberg K. Efficient arsenic metabolism-the AS3MT haplotype is associated with DNA methylation and expression of multiple genes around AS3MT. PLoS One. 2013;8:e53732. doi: 10.1371/journal.pone.0053732. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [17].Schlebusch CM, Lewis CM, Jr, Vahter M, Engström K, Tito RY, Obregón-Tito AJ, Huerta D, Polo SI, Medina AC, Brutsaert TD, Concha G, et al. Possible positive selection for an arsenic-protective haplotype in humans. Environ Health Perspect. 2013;121:53–58. doi: 10.1289/ehp.1205504. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [18].Fu S, Wu J, Li Y, Liu Y, Gao Y, Yao F, Qiu C, Song L, Wu Y, Liao Y, Sun D. Urinary arsenic metabolism in a Western Chinese population exposed to high-dose inorganic arsenic in drinking water: influence of ethnicity and genetic polymorphisms. Toxicol Appl Pharmacol. 2014;274:117–123. doi: 10.1016/j.taap.2013.11.004. [DOI] [PubMed] [Google Scholar]
- [19].Schlebusch CM, Gattepaille LM, Engström K, Vahter M, Jakobsson M, Broberg K. Human adaptation to arsenic-rich environments. Mol Biol Evol. 2015;32:1544–1555. doi: 10.1093/molbev/msv046. [DOI] [PubMed] [Google Scholar]
- [20].Eichstaedt CA, Antao T, Cardona A, Pagani L, Kivisild T, Mormina M. Genetic and phenotypic differentiation of an Andean intermediate altitude population. Phys Rep. 2015;3:e12376. doi: 10.14814/phy2.12376. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [21].Eichstaedt CA, Antao T, Pagani L, Cardona A, Kivisild T, Mormina M. The Andean adaptive toolkit to counteract high altitude maladaptation: genome-wide and phenotypic analysis of the collas. PLoS One. 2014;9:e93314. doi: 10.1371/journal.pone.0093314. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [22].Centro de Ingeniería en Medio Ambiente del Instituto Tecnológico de Buenos Aires. Map of arsenic levels in Argentina [Mapa de arsenico en Argentina - Resultados recopilados de análisis de arsénico] 2015 NutiRed.org La Comisión de Aguas, ITBA, TECHO.
- [23].Weir BS, Cockerham CC. Estimating F-statistics for the analysis of population structure. Evolution. 1984;38:1358–1370. doi: 10.1111/j.1558-5646.1984.tb05657.x. [DOI] [PubMed] [Google Scholar]
- [24].Rousset F. Genepop’007: a complete reimplementation of the Genepop software for Windows and Linux. Mol Ecol Resour. 2008:103–106. doi: 10.1111/j.1471-8286.2007.01931.x. [DOI] [PubMed] [Google Scholar]
- [25].Yi X, Liang Y, Huerta-Sanchez E, Jin X, Cuo ZX, Pool JE, Xu X, Jiang H, Vinckenbosch N, Korneliussen TS, Zheng H, et al. Sequencing of 50 human exomes reveals adaptation to high altitude. Science. 2010;329:75–78. doi: 10.1126/science.1190371. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [26].Shriver MD, Mei R, Bigham A, Mao X, Brutsaert TD, Parra EJ, Moore LG. Finding the genes underlying adaptation to hypoxia using genomic scans for genetic adaptation and admixture mapping. Adv Exp Med Biol. 2006;588:89–100. doi: 10.1007/978-0-387-34817-9_9. [DOI] [PubMed] [Google Scholar]
- [27].Cardona A, Pagani L, Antao T, Lawson DJ, Eichstaedt CA, Yngvadottir B, Shwe MT, Wee J, Romero IG, Raj S, Metspalu M, et al. Genome-wide analysis of cold adaptation in indigenous siberian populations. PLoS One. 2014;9:e98076. doi: 10.1371/journal.pone.0098076. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [28].Pickrell JK, Coop G, Novembre J, Kudaravalli S, Li JZ, Absher D, Srinivasan BS, Barsh GS, Myers RM, Feldman MW, Pritchard JK. Signals of recent positive selection in a worldwide sample of human populations. Genome Res. 2009;19:826–837. doi: 10.1101/gr.087577.108. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [29].Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 2005;21:263–265. doi: 10.1093/bioinformatics/bth457. [DOI] [PubMed] [Google Scholar]
- [30].Carbon S, Ireland A, Mungall CJ, Shu S, Marshall B, Lewis S. AmiGO: online access to ontology and annotation data. Bioinformatics. 2009;25:288–289. doi: 10.1093/bioinformatics/btn615. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [31].Safran M, Dalah I, Alexander J, Rosen N, Iny Stein T, Shmoish M, Nativ N, Bahir I, Doniger T, Krug H, Sirota-Madi A, et al. GeneCards version 3: the human gene integrator. Database J Biol Databases Curation. 2010;2010:aq020. doi: 10.1093/database/baq020. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [32].Ren X, Aleshin M, Jo WJ, Dills R, Kalman DA, Vulpe CD, Smith MT, Zhang L. Involvement of N-6 adenine-specific DNA methyltransferase 1 (N6AMT1) in arsenic biomethylation and its role in arsenic-induced toxicity. Environ Health Perspect. 2012;119:771–777. doi: 10.1289/ehp.1002733. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [33].Harari F, Engström K, Concha G, Colque G, Vahter M, Broberg K. N-6-adenine-specific DNA methyltransferase 1 (N6AMT1) polymorphisms and arsenic methylation in Andean women. Environ Health Perspect. 2013;121:797–803. doi: 10.1289/ehp.1206003. [DOI] [PMC free article] [PubMed] [Google Scholar]




